Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025) (NCT01668784) | Bristol-Myers Squibb | 2012-10-09 |
Track Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.